• Users Online: 359
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2022  |  Volume : 11  |  Issue : 3  |  Page : 79-82

Drug-induced liver injury: A primer for cardiologists

1 Department of Hepatology, Medanta the Medicity, Gurugram, Haryana, India
2 Department of Cardiology, Narayana Multispecialty Hospital, Jaipur, Rajasthan, India
3 Division of Clinical and Preventive Cardiology, Medanta the Medicity, Gurugram, Haryana, India

Correspondence Address:
MD, DM Narendra Singh Choudhary
Department of Hepatology, Medanta the Medicity Hospital, Sector 38, Gurugram, Haryana
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcpc.jcpc_8_22

Rights and Permissions

Although drug-induced liver injury (DILI) is an uncommon diagnosis, it is an important cause of morbidity and mortality in hepatology practice. A timely diagnosis of DILI is important to stop causative drugs and keeping a high index of suspicion is important. There is no gold standard single test to diagnosed DILI, causality scores help in establishing a diagnosis. DILI presenting as acute liver failure is associated with poor prognosis in natural course. The association of nonalcoholic fatty liver disease with cardiac disease makes it more important to think of DILI in a patient with liver dysfunction. We discuss various aspects of DILI in cardiology context in the current review.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded79    
    Comments [Add]    

Recommend this journal